The Pharma & Healthcare industry is of vital importance for human and economic development, providing a wide range of goods and services relevant to the promotion of health at all stages in the healthcare process – from prevention and treatment to rehabilitation and palliative care. It is one of the fastest-growing industries, supported by profound demographic changes, the rising incidence of non-communicable diseases, and surging per capita health spending in both developed and emerging markets. The industry is also one of the major innovators, with increasing expenditures on development of new molecules, biotechnology and adoption of new technologies that provide advanced healthcare and ensure the longevity of the population.
The Pharma & Healthcare industry comprises the manufacture of pharmaceuticals for human and veterinary use, medical equipment and related supplies. It also includes providers of ambulatory health services, medical and diagnostic laboratories, hospitals, and nursing and residential care facilities.
Colombia: Cardioinfantil saves over COP 20bn with automated procurement process
M-Brain - News Monitoring | 2018-Jul-19
Slovakia scores worse in health care than Pakistan, index shows
BBJ - Regional Today | 2018-Jul-19
Budget: UNICEF Tasks Nigeria On 15% Allocation To Health lth
Leadership News | 2018-Jul-19
We aggregate the cream of the world’s industry sources, meaning you have your pick of the research
in just a few clicks. Get an overarching view from global and local providers, meaning you get
your industry view from outside and within. Gain access to EMIS Insights, our own detailed reports
that cover key sectors in the most important markets.
STATISTICS & FORECASTS
Perform complex industry comparisons across multiple industry indicators. Project sustainable growth.
Target key opportunities. Sophisticated screening tools make it simple, allowing you to view,
analyse, chart and export the data you need.
Quickly analyse company or industry trends and rankings. Select relevant financials and compare companies against existing or custom defined industries to assess relative performance and risk.